WO2000009100A3 - Renforçateur du facteur d'induction de la differenciation cellulaire - Google Patents

Renforçateur du facteur d'induction de la differenciation cellulaire Download PDF

Info

Publication number
WO2000009100A3
WO2000009100A3 PCT/JP1999/004338 JP9904338W WO0009100A3 WO 2000009100 A3 WO2000009100 A3 WO 2000009100A3 JP 9904338 W JP9904338 W JP 9904338W WO 0009100 A3 WO0009100 A3 WO 0009100A3
Authority
WO
WIPO (PCT)
Prior art keywords
enhancer
cell differentiation
differentiation induction
induction factor
benzothiepine compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP1999/004338
Other languages
English (en)
Other versions
WO2000009100A2 (fr
Inventor
Haruhiko Makino
Yukio Fujisawa
Masatoshi Hazama
Takashi Sohda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Priority to AU51960/99A priority Critical patent/AU5196099A/en
Priority to EP99937019A priority patent/EP1105140A2/fr
Priority to CA002340165A priority patent/CA2340165A1/fr
Publication of WO2000009100A2 publication Critical patent/WO2000009100A2/fr
Publication of WO2000009100A3 publication Critical patent/WO2000009100A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/67—Phosphorus compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

L'invention porte sur un renforçateur du facteur d'induction de la différenciation cellulaire comprenant un composé de la formule (I) dans laquelle un noyau A est un noyau de benzène éventuellement substitué; R est un atome d'hydrogène ou un groupe d'hydrocarbures éventuellement substitués; B est un groupe carboxyle estérifié ou un groupe amidocarboxyle; X représente -CH(OH)- ou -O-; k vaut 0 ou 1; et k' 0, 1 ou 2. L'invention porte également sur le sel de ce composé, ce composé pouvant être avantageusement utilisé comme renforçateur du facteur d'induction de la différenciation cellulaire.
PCT/JP1999/004338 1998-08-12 1999-08-11 Renforçateur du facteur d'induction de la differenciation cellulaire Ceased WO2000009100A2 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AU51960/99A AU5196099A (en) 1998-08-12 1999-08-11 Enhancer of cell differentiation induction factor
EP99937019A EP1105140A2 (fr) 1998-08-12 1999-08-11 Renfor ateur du facteur d'induction de la differenciation cellulaire
CA002340165A CA2340165A1 (fr) 1998-08-12 1999-08-11 Renforcateur du facteur d'induction de la differenciation cellulaire

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP10/228300 1998-08-12
JP22830098 1998-08-12

Publications (2)

Publication Number Publication Date
WO2000009100A2 WO2000009100A2 (fr) 2000-02-24
WO2000009100A3 true WO2000009100A3 (fr) 2000-08-24

Family

ID=16874304

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP1999/004338 Ceased WO2000009100A2 (fr) 1998-08-12 1999-08-11 Renforçateur du facteur d'induction de la differenciation cellulaire

Country Status (5)

Country Link
EP (1) EP1105140A2 (fr)
AR (1) AR020158A1 (fr)
AU (1) AU5196099A (fr)
CA (1) CA2340165A1 (fr)
WO (1) WO2000009100A2 (fr)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0460488A1 (fr) * 1990-05-30 1991-12-11 Takeda Chemical Industries, Ltd. Composés hétérocycliques contenant du soufre
EP0719782A1 (fr) * 1994-12-28 1996-07-03 Takeda Chemical Industries, Ltd. Dérivé de benzotiépine optiquement actif, sa préparation et son utilisation
WO1996025929A1 (fr) * 1995-02-21 1996-08-29 Takeda Chemical Industries, Ltd. Utilisation de l'helioxanthine comme activateur de facteurs induisant la differenciation cellulaire
WO1996039134A1 (fr) * 1995-06-05 1996-12-12 Takeda Chemical Industries, Ltd. Composition pharmaceutique favorisant l'osteogenese
WO1998008517A2 (fr) * 1996-08-26 1998-03-05 Takeda Chemical Industries, Ltd. Composition pharmaceutique contenant une substance favorisant l'osteogenese et un polyethylene glycol
WO1998009958A1 (fr) * 1996-09-06 1998-03-12 Takeda Chemical Industries, Ltd. 4,5,6,7-tetrahydrobenzo[c]thiopenes condenses utilises comme renforçateurs de l'action des facteurs induisant la differenciation cellulaire

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0460488A1 (fr) * 1990-05-30 1991-12-11 Takeda Chemical Industries, Ltd. Composés hétérocycliques contenant du soufre
EP0719782A1 (fr) * 1994-12-28 1996-07-03 Takeda Chemical Industries, Ltd. Dérivé de benzotiépine optiquement actif, sa préparation et son utilisation
WO1996025929A1 (fr) * 1995-02-21 1996-08-29 Takeda Chemical Industries, Ltd. Utilisation de l'helioxanthine comme activateur de facteurs induisant la differenciation cellulaire
WO1996039134A1 (fr) * 1995-06-05 1996-12-12 Takeda Chemical Industries, Ltd. Composition pharmaceutique favorisant l'osteogenese
WO1998008517A2 (fr) * 1996-08-26 1998-03-05 Takeda Chemical Industries, Ltd. Composition pharmaceutique contenant une substance favorisant l'osteogenese et un polyethylene glycol
WO1998009958A1 (fr) * 1996-09-06 1998-03-12 Takeda Chemical Industries, Ltd. 4,5,6,7-tetrahydrobenzo[c]thiopenes condenses utilises comme renforçateurs de l'action des facteurs induisant la differenciation cellulaire

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
AKIYAMA H ET AL: "TAK-778, a novel synthetic 3-benzothiepin derivative, promotes chondrogenesis in vitro and in vivo.", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, (1999 JUL 22) 261 (1) 131-8., XP000867478 *
KUROKAWA T. ET AL: "A one-step enzyme-linked immunosorbent assay for a novel osteoblast differentiation-promoting compound, TAK-778 in serum.", BIOLOGICAL AND PHARMACEUTICAL BULLETIN, (1999) 22/12 (1266-1270)., December 1999 (1999-12-01), XP000884225 *
ODA, TSUNEO ET AL: "Synthesis of Novel 2-Benzothiopyran and 3-Benzothiepin Derivatives and Their Stimulatory Effect on Bone Formation", J. MED. CHEM. (1999), 42(4), 751-760, July 1999 (1999-07-01), XP000867476 *

Also Published As

Publication number Publication date
AR020158A1 (es) 2002-04-10
EP1105140A2 (fr) 2001-06-13
AU5196099A (en) 2000-03-06
CA2340165A1 (fr) 2000-02-24
WO2000009100A2 (fr) 2000-02-24

Similar Documents

Publication Publication Date Title
AU664663B2 (en) Compounds useful as sweetening agents and process for their preparation
AU1980997A (en) Synthetic Multimerizing Agents
AU3367995A (en) New multimerizing agents
AU3461697A (en) Heterocyclic compounds, their production and use
AU6379290A (en) Tricyclic carbapenem compounds
AU8771591A (en) Retroviral protease inhibiting compounds
EP1238969A3 (fr) Sels de composés de sulfonium
AU8572282A (en) Aromatic ketones
AU3744397A (en) Total synthesis of antitumor acylfulvenes
EP1090922A3 (fr) Composition organophosphorée, procédé de préparation d'un composé organophosphoré, composition de polyester et méthode pour la préparer
AU7332696A (en) Triciclic compounds
AU674839B2 (en) Pyridinecarboximidamide compound and use thereof
GR3036836T3 (en) Sulfur-containing heterocyclic compounds.
SG104327A1 (en) Electron withdrawing group-containing metal compound
ES8801290A1 (es) Un metodo para preparar derivados de cefem
ES8602699A1 (es) Procedimiento para preparar cetonas heterociclicas nitrogenadas con anillo de siete miembros y condensadas.
AU1523395A (en) Gas generant composition containing non-metallic salts of 5-nitrobarbituric acid
WO1997031016A3 (fr) Nouveaux inhibiteurs des processus lies a la presence de sh2
WO1999035133A3 (fr) Chelateurs constitues de derives d'acide 1,4,7,10-tetraazacyclododecane-1,4-diacetique
AU2001282297A1 (en) Catalysts
ZA9419B (en) Preparation process for sulphurated derivatives of imidazole and the new intermediates obtained.
MY122105A (en) Method for preparing substituted 4-phenyl-4-cyanocyclohexanoic acids.
AU1600495A (en) Novel indane-2-mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase
BG103398A (en) New derivatives of erythromicyn, method for their preparation and application as medicmentous forms
WO1999065474A3 (fr) Composition traitant une maladie du cartilage

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AL AM AU AZ BA BB BG BR BY CA CN CR CU CZ DM EE GD GE HR HU ID IL IN IS JP KG KR KZ LC LK LR LT LV MD MG MK MN MX NO NZ PL RO RU SG SI SK SL TJ TM TR TT UA US UZ VN YU ZA

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AL AM AU AZ BA BB BG BR BY CA CN CR CU CZ DM EE GD GE HR HU ID IL IN IS JP KG KR KZ LC LK LR LT LV MD MG MK MN MX NO NZ PL RO RU SG SI SK SL TJ TM TR TT UA US UZ VN YU ZA

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 09743551

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 1999937019

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 2340165

Country of ref document: CA

Ref country code: CA

Ref document number: 2340165

Kind code of ref document: A

Format of ref document f/p: F

WWP Wipo information: published in national office

Ref document number: 1999937019

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1999937019

Country of ref document: EP